N/A N=100 Effectiveness of Thoracic Facet Joint Nerve Blocks
Low Back Pain
Primary: Numeric Rating Scale — 7.9; 7.8; 3.1; 3.1 units on a scale — p=0.964
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=3,472 Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)
Diabetic Retinopathy
Primary: Number of Participants With Progression of Diabetic Retinopathy of at Least 3 Stages on the Early Treatment Diabetic Retinopathy Study (ETDRS) Scale, or Development of…
Phase 2 N=31 Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Fallopian Tube Cancer · Ovarian Cancer · Primary Peritoneal Cancer
Primary: Best Overall Response — 0; 0; 13; 11 participants
N/A N=59 Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
Cocaine Addiction
Primary: Drug Abstinence During Treatment and at Follow up Visits — 12; 25 percentage of drug abstinences
Phase 2 N=20 Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
Wegener's Granulomatosis
Primary: Safety of Abatacept - Number of Participants With Adverse Events — 7; 16; 14; 1 participants
Phase 4 N=91 Graft Patency Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Via Minimally Invasive Coronary Surgery
Arteriosclerosis of Coronary Artery Bypass Graft
Primary: Technical Success (Graft Patency) in a MICS Approach — 100 percentage of grafts
N/A N=60 A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)
Abdominal Aortic Aneurysms
Primary: Rate of Technical Success Through the One Month Follow up. — 54 Participants
N/A N=100 To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research
Pain
Primary: Pressure Pain Threshold (PPT)With 1 cm2 Probe — 2.61; 2.20 kg/cm2
Phase 3 N=336 A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists
Chronic Idiopathic Urticaria
Primary: Percentage of Participants With Adverse Events — 78.3; 83.7 Percentage of participants
Phase 2 N=90 Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias
Richter's Transformation · Leukemia
Primary: Maximum Total Tolerated Dose (MTD) of Daily Combination Fludarabine 30 mg/m^2 and Cytarabine 500 mg/m^2 Among 3 Dose Levels (Dose Level 1: 2 Days, Dose Level 2: 3 Days…
N/A N=120 Effectiveness of Lumbar Facet Joint Nerve Blocks
Low Back Pain
Primary: Average Numeric Rating Scale — 8.2; 7.9; 3.8; 3.5 units on a scale — p=>0.05
Phase 2 N=33 The Effect and Safety of Lisinopril in Non-hypertensive Men With Infertility From Low Sperm Count
Oligospermia
Primary: Changes From Baseline in the Seminal Fluid Characteristics Throughout the Study — 3.47; 3.20 ml
Phase 2 N=40 Sevelamer for Reducing Endotoxemia and Immune Activation
HIV-1 Infection
Primary: Change in Endotoxin — 0.20 pg/mL — p=0.87
Phase 4 N=72 Effects of a Common Cold Treatment on Cognitive Function
Common Cold
Primary: Adjusted Mean Change From Baseline in Number of Valid Responses to Rapid Visual Information Processing (RVIP) Cognitive Test — 4.8; 1.3 Valid responses — p=0.0008
N/A N=120 The Realtime Detection for Individual Variation of Analgesic ：A Comparison of Sufentanil vs Fentanyl
Surgery · Individuality
Primary: Mean Pressure Pain Threshold — 9.93; 6.20; 2.36 kg/cm2